Stock analysis, AI verdict, fundamentals & technical signals
Rating: NEUTRAL
Price: $4.10 Analyst target: $18.00 Upside: 339.02%
ImageneBio, Inc., a clinical-stage biotechnology company, develops therapeutics for immunological and inflammatory diseases. The company is headquartered in San Diego, California.
See the full interactive analysis & chart →Informational only — not investment advice.